# TALARIS THERAPEUTICS INC (TALS)

> Institutional ownership reported to the SEC as of Q3 2024, from Form 13F filings. Source: https://holderbook.com/stocks/TALS/

- Reporting holders: 1
- Reported value: $1.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Lindbrook Capital, LLC](https://holderbook.com/funds/1767045-lindbrook-capital-llc/) | $1.4K | 56 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2024 | 1 | $1.4K |
| Q3 2023 | 48 | $77.1M |
| Q2 2023 | 58 | $79.7M |
| Q1 2023 | 53 | $50.6M |
| Q4 2022 | 52 | $27.4M |
| Q3 2022 | 52 | $72.2M |
| Q2 2022 | 57 | $130.4M |
| Q1 2022 | 51 | $286.9M |
| Q4 2021 | 51 | $456.7M |
| Q3 2021 | 48 | $349.4M |
| Q2 2021 | 50 | $379.4M |